9
Jul
Dr. Frischmuth gives an interview about our vaccine development
The mRNA vaccines have the great advantage that they can be developed very quickly and in a modular fashion. We can even change the genes
MORE →-
-
9
JulMilestone for BioNTech
325 Million USD for further development of its cancer immunotherapy. Learn more at:
MORE → -
22
AprEli Lilly and Avidity Biosciences announce licensing & research cooperation
on combined monoclonal antibodies and oligonucleotide-based therapies for potential new medicines in immunology and other select indications. Read more here:
MORE →